An inherited NBN mutation is associated with poor prognosis prostate cancer.

doi:10.1038/bjc.2012.486

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

An inherited NBN mutation is associated with poor prognosis prostate cancer.

British journal of cancer - 5 Feb 2013

Cybulski C, Wokołorczyk D, Kluźniak W, Jakubowska A, Górski B, Gronwald J, Huzarski T, Kashyap A, Byrski T, Dębniak T, Gołąb A, Gliniewicz B, Sikorski A, Switała J, Borkowski T, Borkowski A, Antczak A, Wojnar L, Przybyła J, Sosnowski M, Małkiewicz B, Zdrojowy R, Sikorska-Radek P, Matych J, Wilkosz J, Różański W, Kiś J, Bar K, Bryniarski P, Paradysz A, Jersak K, Niemirowicz J, Słupski P, Jarzemski P, Skrzypczyk M, Dobruch J, Domagała P, Narod S A, Lubiński J

Abstract excerpt

BACKGROUND: To establish the contribution of eight founder alleles in three DNA damage repair genes (BRCA1, CHEK2 and NBS1) to prostate cancer in Poland, and to measure the impact of these variants on survival among patients. METHODS: Three thousand seven hundred fifty men with prostate cancer and 3956 cancer-free controls were genotyped for three founder alleles in BRCA1 (5382insC, 4153delA, C61G), four alleles...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Cycle Proteins

Share to Checkpoint Kinase 2

Share to Genes, BRCA1

Share to Kaplan-Meier Estimate

Share to Nuclear Proteins

Share to Prostatic Neoplasms

Share to Protein Serine-Threonine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 23149842
DOI: 10.1038/bjc.2012.486
PMCID: PMC3566821

Genes

BRCA1
CHEK2
NBN

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An inherited NBN mutation is associated with poor prognosis prostate cancer.PMID 23149842Read ↗

Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men.Semantic proximity Read ↗

Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.Semantic proximity Read ↗

Inherited NBN Mutations and Prostate Cancer Risk and SurvivalSemantic proximity Read ↗

NBS1 is a prostate cancer susceptibility gene.Semantic proximity Read ↗

Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer.Semantic proximity Read ↗

A personalised approach to prostate cancer screening based on genotyping of risk founder alleles.Semantic proximity Read ↗

DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794).Semantic proximity Read ↗

PALB2 mutations and prostate cancer risk and survival.Semantic proximity Read ↗

A common nonsense mutation of the BLM gene and prostate cancer risk and survival.Semantic proximity Read ↗

The prognostic impact of high Nijmegen breakage syndrome (NBS1) gene expression in ERG‐negative prostate cancers lacking PTEN deletion is driven by KPNA2 expressionSemantic proximity Read ↗

BRCA1 mutations and prostate cancer in Poland.Semantic proximity Read ↗

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.